Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide Irrigations for Chronic Rhinosinusitis
NCT03519061Phase 3Withdrawn
- Sponsor
- Kaiser Permanente
- Start
- Aug 2019
- Primary completion
- Aug 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide in chronic rhinosinusitis (CRS), sponsored by Kaiser Permanente. Planned start Aug 2019; status: withdrawn.
02
Drugs
budesonide
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT03519061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03519061.